![Paul Spence](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Spence
Corporate Officer/Principal bei OPTINOSE, INC.
Vermögen: 272 889 $ am 31.05.2024
Aktive Positionen von Paul Spence
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OPTINOSE, INC. | Corporate Officer/Principal | 15.12.2022 | - |
Karriereverlauf von Paul Spence
Ehemalige bekannte Positionen von Paul Spence
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2020 | 01.01.2022 |
Nestle Health Science SA
![]() Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Corporate Officer/Principal | 01.01.2016 | 01.01.2019 |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - | - |
Ausbildung von Paul Spence
Villanova University | Masters Business Admin |
The Pennsylvania State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 4 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OPTINOSE, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Nestle Health Science SA
![]() Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Health Technology |
Aimmune Therapeutics, Inc.
![]() Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Börse
- Insiders
- Paul Spence
- Erfahrung